Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (251-260 of 338) with videos related to

Pageof 34
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgeryWon Kyung Cho, Dongryul Oh, Hong Kwan Kim, et al.
Cancers|April 16, 2020
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal CancerHan Gyul Yoon, Dongryul Oh, Yong Chan Ahn, et al.
Annals of Surgical Oncology|February 14, 2014
Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapyHyebin Lee, Yong Chan Ahn, Hongryull Pyo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 24, 2024
Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinomaTae Hee Hong, Tae Ho Kim, Genehee Lee, et al.
Cancer Research and Treatment|October 30, 2015
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell CarcinomaHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|January 6, 2017
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute ExperienceHyojung Park, Dongryul Oh, Yong Chan Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2013
A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapyJin Seok Ahn, Ki Hyeong Lee, Jong-Mu Sun, et al.
Plos Genetics|August 22, 2015
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid CancerJun Ho Ji, Young Lyun Oh, Mineui Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2016
Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?Hakyoung Kim, Yong Chan Ahn, Hongryull Pyo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2012
Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgeryHee Kyung Ahn, Yoon-La Choi, Joung Ho Han, et al.
Pageof 34

Showing results (251-260 of 338) with videos related to

Sort By:
Pageof 34
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgeryWon Kyung Cho, Dongryul Oh, Hong Kwan Kim, et al.
Cancers|April 16, 2020
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal CancerHan Gyul Yoon, Dongryul Oh, Yong Chan Ahn, et al.
Annals of Surgical Oncology|February 14, 2014
Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapyHyebin Lee, Yong Chan Ahn, Hongryull Pyo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 24, 2024
Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinomaTae Hee Hong, Tae Ho Kim, Genehee Lee, et al.
Cancer Research and Treatment|October 30, 2015
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell CarcinomaHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|January 6, 2017
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute ExperienceHyojung Park, Dongryul Oh, Yong Chan Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2013
A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapyJin Seok Ahn, Ki Hyeong Lee, Jong-Mu Sun, et al.
Plos Genetics|August 22, 2015
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid CancerJun Ho Ji, Young Lyun Oh, Mineui Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2016
Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?Hakyoung Kim, Yong Chan Ahn, Hongryull Pyo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2012
Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgeryHee Kyung Ahn, Yoon-La Choi, Joung Ho Han, et al.
Pageof 34